Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Behcet Syndrome

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Behcet Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aksu, K; Doganavsargil, E; Huseyinov, A; Keser, G; Oksel, F; Pirildar, T; Terzioglu, E; Tunc, SE; Turk, T1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Behcet Syndrome

ArticleYear
Platelet-activating factor and P-selectin activities in thrombotic and nonthrombotic Behçet's patients.
    Rheumatology international, 2005, Volume: 25, Issue:5

    Topics: Adult; Behcet Syndrome; Calcimycin; Cells, Cultured; Cross-Sectional Studies; Female; Humans; Ionophores; Leukocytes; Male; P-Selectin; Platelet Activating Factor; Venous Thrombosis

2005